ELIZABETH RICE: Open Payments
NPI 1902470537 · CARLSBAD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,012 in 249 payments from 24 companies in 2025. Trend: 2023 $2,352 · 2024 $5,750 · 2025 $5,012
Food & beverage: $5,012
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 60 | $1,374 |
| SK Life Science, Inc. | 51 | $628 |
| Neurocrine BioSciences, Inc. | 31 | $594 |
| Medtronic, Inc. | 7 | $460 |
| Amneal Pharmaceuticals LLC | 16 | $354 |
| PFIZER INC. | 21 | $289 |
| Teva Pharmaceuticals USA, Inc. | 18 | $257 |
| Lundbeck LLC | 9 | $214 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Merz Pharmaceuticals, LLC | 4 | $107 |
Products named: INGREZZA, QULIPTA, PERCEPT PC BRAINSENSE, BOTOX, CREXONT, AUSTEDO XR, VYEPTI, VYALEV.
Industry payments across CA — which companies pay providers there.
